Contributions of peripheral and central opioid receptors to antinociception in rat muscle pain models

Pharmacology Biochemistry and Behavior

Volumn 96, Issue 4, 2010, Pages 488-495

  Sánchez, Eva Ma ^a   Bagües, Ana ^a   Martín, Ma Isabel ^a  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

Gastrocnemius; Hypertonic saline; Masseter; Muscular pain; Opioid; Triceps

Indexed keywords

17 METHYLNALOXONE; CREMOPHOR; LOPERAMIDE; MORPHINE; NALOXONE; OPIATE RECEPTOR; SODIUM CHLORIDE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DISEASE MODEL; GASTROCNEMIUS MUSCLE; MALE; MASSETER MUSCLE; MYALGIA; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL NERVE; TAIL FLICK TEST; TRICEPS BRACHII MUSCLE; TRIGEMINAL NERVE; WITHDRAWAL REFLEX;

RATTUS;

EID: 77956063477     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.07.009     Document Type: Article

References (44)

1. Ambriz-Tututi M., Rocha-González H.I., Castañeda-Corral G., Araiza-Saldaña C.I., Caram-Salas N.L., Cruz S.L., et al. Role of opioid receptors in the reduction of formalin-induced secondary allodynia and hyperalgesia in rats. Eur J Pharmacol 2009, 619:25-32.
2. Bennet G.J. Animal models of pain. Methods in pain research 2001, 67-91. CRC Press, Boca Ratón, Florida. L. Kruger (Ed.).
3. Burgos E., Pascual D., Martín M.I., Goicoechea C. Antinociceptive effect of the cannabinoid agonist, WIN 55, 212-2, in the orofacial and temporomandibular formalin tests. Eur J Pain 2010, 14(1):40-48.
4. Capra N.F., Ro J.Y. Human and animal experimental models of acute and chronic muscle pain: intramuscular algesic injection. Pain 2004, 110:3-7.
5. D'Amour F.E., Smith D.L. A method for determining loss of pain sensation. J Pharmacol Exp Ther 1941, 41:419-424.
6. DeHaven-Hudkins D.L., Dolle R.E. Peripherally restricted opioid agonists as novel analgesic agents. Curr Pharm Des 2004, 10:743-757.
7. DeHaven-Hudkins D.L., Burgos L.C., Cassel J.A., Daubert J.D., DeHaven R.N., Mansson E., et al. Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity. J Pharm Exp Ther 1999, 289:494-502.
8. Dood J., Kelly J.P. Trigeminal system. Principles of neural science 1991 1991, vol. 3:701-710. Elsevier, New York.
9. Fujii Y., Ozaki N., Taguchi T., Mizumura K., Furukawa K., Sugiura Y. TRP channels and ASICs mediate mechanical hyperalgesia in models of inflammatory muscle pain and delayed onset muscle soreness. Pain 2008, 140:292-304.
10. Graven-Nielsen T. Fundamentals of muscle pain, referred pain and deep tissue hyperalgesia. Scand J Rheumatol 2006, 35(122):1-43.
11. Guan Y., Johanek L.M., Hartke T.V., Shim B., Tao Y.X., Ringkamp M., et al. Peripherally acting mu-opioid receptor agonist attenuates neuropathic pain in rats after L5 spinal nerve injury. Pain 2008, 138(2):318-329.
12. Han S.R., Lee M.K., Lim K.H., Yang G.Y., Jeon H.J., Ju J.S., et al. Intramuscular administration of morphine reduces mustard oil-induced craniofacial muscle pain behaviour in lightly anesthetized rats. Eur J Pain 2008, 12:361-370.
13. Kabli N., Cahill C.M. Anti-allodynic effects of peripheral delta opioid receptors in neuropathic pain. Pain 2007, 127:84-93.
14. Kehl L.J., Trempe T.M., Hargreaves K.M. A new animal model for assesing mechanisms and management of muscle hyperalgesia. Pain 2000, 85:333-343.
15. Kelgren J.H. Observations on referred pain arising from muscle. Clin Sci 1938, 3:175-190.
16. Labuz D., Mousa S.A., Schäfer M., Stein C., Machelska H. Relative contribution of peripheral versus central opioid receptors to antinociception. Brain Res 2007, 1160:30-38.
17. Lewanowitsch T., Irvine R. Naloxone methiodide reverses opioid-induced respiratory depression and analgesia without withdrawal. Eur J Pharmacol 2002, 445:61-67.
18. Li S., Zhao Z.Q. Morphine-induced decrease in mechanical allodynia is mediated by central, but not peripheral, opioid receptors in rats with inflammation. Eur J Pharmacol 2003, 481(2-3):203-206.
19. Machelska H., Schopoha J.K., Mousa S.A., Labuz D., Schäfer M., Stein C. Different mechanisms of intrinsic pain inhibition in early and late inflammation. J Neuroimmunol 2003, 141:30-39.
20. Martin H.A., Arendt-Nielsen L. Effect of muscle pain and intrathecal AP-5 on electromyographic patterns during treadmill walking in the rat. Prog Neuropsychopharmacol Biol Psychiatry 2000, 24(7):1151-1175.
21. Mecs L., Tuboly G., Nagy E., Benedek G., Horvath G. The peripheral antinociceptive effects of endomorphin-1 and kynurenic acid in the rat inflamed joint model. Anesth Analg 2009, 109(4):1297-1304.
22. Mense S. Algesic agents exciting muscle nociceptors. Exp Brain Res 2009, 196(1):89-100.
23. Nielsen A.N., Mathiesen C., Blackburn-Munro G. Pharmacological characterisation of acid-induced muscle allodynia in rats. Eur J Pharmacol 2004, 487(1-3):93-103.
24. Nuñez S., Lee J.S., Zhang Y., Bai G., Ro J.Y. Role of peripheral μ-opioid receptors in inflammatory orofacial muscle pain. Neuroscience 2007, 146:1346-1354.
25. Obara I., Makuch W., Spetea M., Schütz J., Schmidhammer H., Przewlocki R. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat. Eur J Pharmacol 2007, 558:60-67.
26. Obara I., Parkitna J.R., Korostynski M., Makuch W., Kaminska D., Przewlocka B., et al. Local peripheral opioid effects and expression of opioid genes in the spinal cord and dorsal root ganglia in neuropathic and inflammatory pain. Pain 2009, 141:283-291.
27. Ossipov M., Lai J., King T., Vanderah T., Malan T., Hruby V., et al. Antinociceptive and nociceptive actions of opioids. J Neurobiol 2004, 61:126-148.
28. Pelissier T., Pajot J., Dallel R. The orofacial capsaicin test in rats: effects of different capsaicin concentrations and morphine. Pain 2002, 96:81-87.
29. Ro J.Y. Contribution of peripheral NMDA receptors in craniofacial muscle nociception and edema formation. Brain Res 2003, 979:78-84.
30. Ro J.Y., Capra N., Masri R. Development of a behavioral assessment of craniofacial muscle pain in lightly anesthetized rats. Pain 2003, 104:179-185.
31. Ro J.Y., Lee J.S., Zhang Y. Activation of TRPV1 and TRPA1 leads to muscle nociception and mechanical hyperalgesia. Pain 2009, 144:270-277.
32. Russell J., Bass P., Goldberg L., Schuster C., Merz H. Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists. Eur J Pharmacol 1982, 78:255-261.
33. Santos L.C., De Moraes A.N., Saito M.E. Effects of intraarticular ropivacaine and morphine on lipopolysaccharide-induced synovitis in horses. Vet Anaesth Analg 2009, 36(3):280-286.
34. Sessle B.J. Peripheral and central mechanisms of orofacial pain and their clinical correlates. Minerva Anestesiol 2005, 71:117-136.
35. Sevostianova N., Danysz W., Bespalov A.Y. Analgesic effects of morphine and loperamide in the rat formalin test: interactions with NMDA receptor antagonists. Eur J Pharmacol 2005, 525:83-90.
36. Shinoda M., Ozaki N., Sugiura Y. Involvement of ATP and its receptors on nociception in rat model of masseter muscle pain. Pain 2008, 134:148-157.
37. Sluka K.A., Rohlwing J.J., Bussey R.A., Eikenberry S.A., Wilken J.M. Chronic muscle pain induced by repeated acid injection is reversed by spinally administered mu- and delta-, but not kappa-opioid receptor agonists. J Pharmacol Exp Ther 2002, 302:1146-1150.
38. Stein C., Machelska H., Schafer M. Peripheral analgesic and anti-inflammatory effects of opioids. Z Rheumatol 2001, 60:416-424.
39. Stohler C.S., Lund J.P. Effects of noxious stimulation of the jaw muscles on the sensory experience of volunteer human subjects. Biological and psychological aspects of orofacial pain 1994, 55-73. The University of Michigan Center for Human Growth and Development, Ann Arbor, Michigan. C.S. Stohler, D.S. Carlson (Eds.).
40. Takemura M., Sugiyo S., Moritani M., Kobayashi M., Yonehara N. Mechanisms of orofacial pain control in the central nervous system. Arch Histol Cytol 2006, 69:79-100.
41. Truong W., Cheng C., Xu Q.G., Li X.Q., Zochodne D.W. Mu opioid receptors and analgesia at the site of a peripheral nerve injury. Ann Neurol 2003, 53:366-375.
42. Yaksh T. Spinal systems and pain processing: development of novel analgesic drugs with mechanistically defined models. Trends Pharmacol Sci 1999, 20:329-337.
43. Yokoyama T., Maeda Y., Audette K., Sluka K.A. Pregabalin reduces muscle and cutaneous hyperalgesia in two models of chronic muscle pain in rats. J Pain 2007, 8(5):422-429.
44. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110.